compound 1 [PMID: 19233845]   Click here for help

GtoPdb Ligand ID: 14669

Synonyms: RTP Type O inhibitor Pi
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: This compound is reported as a non-specific SHP2 (protein tyrosine phosphatase non-receptor type 11; PTPN11) inhibitor with activity against other receptor and non-receptor class tyrosine phosphatases, including RTP Type O (PTPRO; GLEPP1), SHP1 (PTPN6) and PTP1B [1-2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 12
Topological polar surface area 60.77
Molecular weight 483.64
XLogP 9.3
No. Lipinski's rules broken 2

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCCCCN(CC1=CC=C(C#CC2=CC=C(CCCC)C=C2)C=C1)C3=CC=C(C(=C3)C(=O)O)O
Isomeric SMILES C(CCC)C1=CC=C(C=C1)C#CC2=CC=C(C=C2)CN(C=3C=CC(=C(C(=O)O)C3)O)CCCCCC
InChI InChI=1S/C32H37NO3/c1-3-5-7-8-22-33(29-20-21-31(34)30(23-29)32(35)36)24-28-18-16-27(17-19-28)15-14-26-12-10-25(11-13-26)9-6-4-2/h10-13,16-21,23,34H,3-9,22,24H2,1-2H3,(H,35,36)
InChI Key FQMKKDYJAKJVRO-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Immunopharmacology Comments
This compound can be used experimentally. It produces an anti-inflammatory action by blocking dephosphorylation of PTPRO substrates SYK1 and paxillin in resting cells, which results in disruption of primary human monocyte and mouse bone marrow-derived macrophage chemotaxis.